# RNA Bio/Pharma Inc – FDA Inspection, Apr 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/rna-biopharma-inc/c7c1c61f-a078-481e-a9be-bf3a44e4cb45
Source feed: FDA_Inspections

> FDA inspection 1266530 of RNA Bio/Pharma Inc, April 11, 2025. Classification: Official Action Indicated (OAI). 4 citations under 21 CFR part 211. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266530
- Company Name: RNA Bio/Pharma Inc
- Inspection Date: 2025-04-11
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Seattle District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1097487 - 2019-06-25](https://www.keypedia.com/records/fda_inspections/rna-biopharma-inc/58bd4338-cb62-4236-a20d-dc658eeaeb9d)
- FDA Inspection 1030091 - 2017-09-20
- [FDA Inspection 834118 - 2013-05-24](https://www.keypedia.com/records/fda_inspections/rna-biopharma-inc/2761eafe-63ef-4139-ac28-4ccbb5ca4b39)
- [FDA Inspection 546350 - 2008-10-31](https://www.keypedia.com/records/fda_inspections/rna-biopharma-inc/cc9c040b-95a3-4a1e-bbbe-b8b245927f41)

## Related Officers

- [Bryan L. Mcguckin](https://www.keypedia.com/people/bryan-l-mcguckin/33eaa16d-a642-4945-81f3-5d9ac180c2db)

Company: https://www.keypedia.com/companies/rna-biopharma-inc/eacb25ab-7668-444a-be5f-52117a9e5b63

Office: https://www.keypedia.com/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913